Menu
Close
News

UW clinical trial tests new way to treat glioblastoma

December 21, 2023
Science & Technology
Share

A new clinical trial at UW Health | Carbone Cancer Center uses a personalized medicine method to try to teach the immune system to recognize and destroy glioblastoma tumors.

The phase 2b trial is evaluating whether implanting diffusion chambers containing a patient’s dying tumor cells can coax their immune system to find and destroy cancer cells. Dr. Ankush Bhatia, assistant professor of neurology at UW School of Medicine and Public Health, is serving as site Principal Investigator.

Carbone Cancer Center is one of about two dozen cancer centers testing this new immunotherapy approach to treating one of the deadliest cancers.

Read more at uwhealth.org

Tags
Cancer

More News

A man analyzing brain scans.
Honors & Awards
January 9, 2024

UW–Madison receives $150 million grant to lead nationwide Alzheimer’s disease study

The University of Wisconsin School of Medicine and Public Health has been awarded funding from the National Institutes of Health for a nationwide research initiative to investigate the neurobiology of Alzheimer’s disease and related dementias.
Dan Hellenbrand
Science & Technology
December 13, 2023

UW researcher’s career inspired by his own spinal cord injury

Dan Hellenbrand grew up on a small farm near Lodi and by his 20s was on the path to his desired career in carpentry. Then, in an instant, that path vanished.